STEROID CYCLES - AN OVERVIEW

At the end of their cycle, hematocrit stages had greater by 3%-place in contrast with baseline. The rise was not connected to for a longer time use or higher AAS dose. A reason for this could possibly be that, beyond a certain level of androgenic action, no additional boost of hematocrit occurs: a ‘ceiling outcome’. Notably, Whilst only five% o